low sensitivity score was the dementia group. Even these
individuals still obtained a score of greater than 92% on
Trial 2. The finding that the scores on the TOMM were
less than 95% for the dementia group is not particularly
negative since it is unlikely that feigning memory impair-
ment is a major issue when dementia patients undergo
neuropsychological assessment.
It should be noted that “below-chance” perfor-
mance (<18 correct at the 95% confidence level) also
can be used as a statistical decision rule. However,
experience has shown that malingerers or individuals
simulating malingerers do not ordinarily obtain below-
chance scores on the TOMM on any trial. Of course, if
they do, the decision rule can be applied.
Five experiments using different types of partici-
pants and different types of experimental designs pro-
vide evidence that the TOMM readily differentiated
between malingering and nonmalingering individuals
and show that the TOMM is a useful psychometric test
for detecting exaggerated or deliberately faked memory
impairment. In this context, it should be noted that the
TOMM meets all the guidelines established in Daubert
v. Merrell Dow Pharmaceuticals(1993) to define the
generally accepted standards for judges to use in deter-
mining the scientific admissibility of evidence, particu-
larly when presented by expert witnesses.
Interpreting the TOMM
Interpretation of the TOMM should never be made
solely on the basis of the TOMM score that a patient
achieves. It depends on many factors, starting with the
basic conceptual issues on how malingeringis defined.
The TOMM does not measure a general trait called
“malingering.” In forensic assessments, the TOMM is
not an appropriate test to evaluate whether or not a per-
son is faking a psychiatric disorder any more than it
would be appropriate to use it to determine if a person is
faking a back injury. Moreover, the interpretation of the
TOMM should not be used to identify a “malingerer”
but rather to indicate that a person is putting forth less
than the maximum effort. Although individuals
malinger, malingering cannot be legitimately viewed as
a personality trait. Malingering in one situation does not
necessarily mean that the person will always malinger
or, in fact, will ever malinger again. In many, if not most,
instances, individuals with TBI who malinger are
“good” people caught in “bad” situations. It must also
be remembered that malingering is not an all-or-none
phenomenon but that it exists in different degrees,
ranging from minor exaggeration of existing symptoms
to flagrant faking of nonexistent symptoms.
Tom N. Tombaugh
See alsoForensic Assessment; Malingering
Further Readings
Daubert v. Merrell Dow Pharmaceuticals, 509
U.S. 579 (1993).
Lynch, W. J. (2004). Determination of effort level,
exaggeration, and malingering in neurocognitive
assessment. Journal of Heat Trauma Rehabilitation,
19,277–283.
Multi-Health Systems. (2006). Test of Memory Malingering
(TOMM). Research monograph: Summary application
in clinical and research settings.Toronto, ON,
Canada: Author.
Tombaugh, T. N. (1996). The Test of Memory Malingering
(TOMM). Toronto, ON, Canada: Multi-Health
Systems.
Tombaugh, T. N. (2002). The Test of Memory Malingering
(TOMM) in forensic psychology. Journal of Forensic
Neuropsychology, 2,69–96.
Vallabhajosula, B., & VanGorp, W. G. (2001). Post-Daubert
admissibility of scientific evidence on malingering of
cognitive deficits. Journal of the American Academy of
Psychiatry and the Law, 29,207–215.
THERAPEUTICCOMMUNITIES FOR
TREATMENT OFSUBSTANCEABUSE
Therapeutic communities use interpersonal interactions
within a structured community milieu to treat substance
abuse. They have shown promising outcomes, espe-
cially among people with substance use disorders who
require a highly structured environment to succeed.
Therapeutic communities are used frequently in correc-
tional institutions to treat inmates with severe substance
use disorders and who exhibit antisocial behavior.
Positive outcomes have been found for many partici-
pants, such as reduced substance use and recidivism
after release from incarceration. Since therapeutic com-
munities focus on communal processes to facilitate
change, this treatment may not be an effective means to
individualize care. In addition, the communities may
not be helpful for autonomous, high-functioning indi-
viduals or people with severe co-occurring psychiatric
802 ———Therapeutic Communities for Treatment of Substance Abuse
T-Cutler (Encyc)-45463.qxd 11/18/2007 12:44 PM Page 802